References
Hahn, T. J., Hendin, B. A., Scharp, C. R., Boisseau, V. C., Haddad, J. G.: Serum 25-hydroxycalciferol levels and bone mass in children on chronic anticonvulsant therapy, N. Engl. J. Med.292:550–554, 1975
Hill, L. F., Lumb, G. A., Mawer, E. B., Stanbury, S. W.: Indirect inhibition of the biosynthesis of 1,25 dihydroxycholecalciferol in rats treated with a diphosphonate, Clin. Sci.44, 335–347, 1973
Khairi, M. R. A., Altman, R. D., DeRosa, G. P., Zimmermann, J., Schenk, R. K., Johnston, C. C.: Sodium etidronate in the treatment of Paget's disease of bone, Ann. Intern. Med.87:656–663, 1977
DeRose, J., Singer, F. R., Avramides, A., Flores, A., Dziadiw, R., Baker, R. K., Wallach, S.: Response of Paget's disease to porcine and salmon calcitonins, Am. J. Med.56:858–866, 1974
Plasmans, C. M. T., Jap, P. H. K., Kuijpers, W., Slooff, T. J. J. H.: Influence of a diphosphonate on the cellular aspect of young bone tissue, Calcif. Tissue Int.32, 247–256, 1980
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Perry, H.M., Avioli, L.V. Effect of sodium etidronate and phenytoin on pagetic bone. Calcif Tissue Int 33, 285–286 (1981). https://doi.org/10.1007/BF02409451
Issue Date:
DOI: https://doi.org/10.1007/BF02409451